» Articles » PMID: 15737097

Regression Modeling of Competing Risks Data Based on Pseudovalues of the Cumulative Incidence Function

Overview
Journal Biometrics
Specialty Public Health
Date 2005 Mar 2
PMID 15737097
Citations 126
Authors
Affiliations
Soon will be listed here.
Abstract

Typically, regression models for competing risks outcomes are based on proportional hazards models for the crude hazard rates. These estimates often do not agree with impressions drawn from plots of cumulative incidence functions for each level of a risk factor. We present a technique which models the cumulative incidence functions directly. The method is based on the pseudovalues from a jackknife statistic constructed from the cumulative incidence curve. These pseudovalues are used in a generalized estimating equation to obtain estimates of model parameters. We study the properties of this estimator and apply the technique to a study of the effect of alternative donors on relapse for patients given a bone marrow transplant for leukemia.

Citing Articles

Estimands and Cumulative Incidence Function Regression in Clinical Trials: Some New Results on Interpretability and Robustness.

Buhler A, Cook R, Lawless J Stat Med. 2024; 43(29):5513-5533.

PMID: 39468894 PMC: 11589047. DOI: 10.1002/sim.10236.


Competing risks data in clinical oncology.

Kim H Front Oncol. 2024; 14:1360266.

PMID: 38638853 PMC: 11024219. DOI: 10.3389/fonc.2024.1360266.


The role of depression in the association between mobilisation timing and live discharge after hip fracture surgery: Secondary analysis of the UK National Hip Fracture Database.

Milton-Cole R, Goubar A, Ayis S, OConnell M, Kristensen M, Schuch F PLoS One. 2024; 19(4):e0298804.

PMID: 38574013 PMC: 10994389. DOI: 10.1371/journal.pone.0298804.


Pseudo-value regression trees.

Schenk A, Berger M, Schmid M Lifetime Data Anal. 2024; 30(2):439-471.

PMID: 38403840 PMC: 11297840. DOI: 10.1007/s10985-024-09618-x.


Increased Cardiac Risk After a Second Malignant Neoplasm Among Childhood Cancer Survivors: A FCCSS Study.

Charrier T, Haddy N, Schwartz B, Journy N, Fresneau B, Demoor-Goldschmidt C JACC CardioOncol. 2024; 5(6):792-803.

PMID: 38205003 PMC: 10774765. DOI: 10.1016/j.jaccao.2023.07.008.